NOVAST Laboratories, Limited (SHE:301569)

NOVAST Laboratories Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	311.22	227.82	260.15	115.79	113	89.61
Depreciation & Amortization	35.34	35.34	34.14	34.07	32.68	32.23
Other Amortization	0.53	0.53	0.5	0.43	-	-
Loss (Gain) From Sale of Assets	-	-	-	-	-33.01	-
Asset Writedown & Restructuring Costs	0.14	0.14	0.16	1.53	0.43	1.64
Loss (Gain) From Sale of Investments	-2.5	-2.5	-3.38	-4.19	-5.62	-4.54
Stock-Based Compensation	59.49	59.49	4.92	82.95	103.91	71.62
Provision & Write-off of Bad Debts	1.57	1.57	-0.87	1.05	-5.22	4.82
Other Operating Activities	-36.43	-11.74	-13.96	-2.58	3.78	8.47
Change in Accounts Receivable	-18.7	-18.7	-16.54	-27.84	44.71	-79.98
Change in Inventory	-5.85	-5.85	18.03	-19.3	-83	39.69
Change in Accounts Payable	37.14	37.14	-17.2	22.89	48.21	-4.75
Change in Unearned Revenue	-	-	-	-	-4.57	7.39
Operating Cash Flow	381.29	322.58	267.02	200.91	209.21	166.2
Operating Cash Flow Growth	-	20.81%	32.90%	-3.97%	25.88%	-3.96%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-64.73	-75.3	-105.86	-126.96	-69.79	-35.8
Sale of Property, Plant & Equipment	0.1	-	0.01	0.19	42.88	0.03
Investment in Securities	-152.24	-169.44	-110.49	-83.22	-212	43.5
Other Investing Activities	-176.29	2.5	3.59	4.89	-72.37	-215.04
Investing Cash Flow	-393.16	-242.24	-212.74	-205.1	-311.28	-207.32

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	-	-	-	-	150
Net Debt Issued (Repaid)	-	-	-	-	-	150
Issuance of Common Stock	-	-	-	-	69.34	75.31
Common Dividends Paid	-	-68	-	-	-	-52.94
Other Financing Activities	-2.65	-4.7	-2.82	-3.39	-7.42	-78.41
Financing Cash Flow	-2.65	-72.7	-2.82	-3.39	61.92	93.96

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-28.67	-18.27	9.05	7.48	23.46	-2.53
Net Cash Flow	-43.2	-10.64	60.52	-0.1	-16.69	50.3

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	316.55	247.28	161.16	73.96	139.42	130.4
Free Cash Flow Growth	-	53.44%	117.92%	-46.95%	6.92%	-7.09%
Free Cash Flow Margin	31.35%	27.62%	18.61%	10.56%	25.35%	20.17%
Free Cash Flow Per Share	0.42	0.33	0.21	0.10	0.18	0.22
Levered Free Cash Flow	-	153.77	153.9	49.57	166.94	14.37
Unlevered Free Cash Flow	-	153.77	153.9	49.57	166.94	16.75

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	67.68	32.67	35.3	20.97	21.15	15.89
Change in Working Capital	11.92	11.92	-14.63	-28.15	-0.74	-37.65

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error